Werbung
Werbung

CAI

C

Caris Life Sciences, Inc. Common Stock

28.80
USD
Gesponsert
+0.42
+1.48%
07. Jan., 16:00 UTC -5
Geschlossen
exchange

Nach-Markt

28.93

+0.13
+0.44%

CAI Ergebnisberichte

Positives Überraschungsverhältnis

CAI übertreffen die 1 der letzten 2Schätzungen.

50%

Nächster Bericht

Datum des nächsten Berichts
--
Estimate for Q-- -- (Revenue/ EPS)
--
/
--
Implizierte Änderung von Q3 25 (Revenue/ EPS)
--
/
--
Implizierte Änderung von Q-- -1 (Revenue/ EPS)
--
/
--

Caris Life Sciences, Inc. Common Stock earnings per share and revenue

On 05. Nov. 2025, CAI reported earnings of 0.08 USD per share (EPS) for Q3 25, beating the estimate of -0.21 USD, resulting in a 138.66% surprise. Revenue reached 216.83 million, compared to an expected 171.86 million, with a 26.17% difference. The market reacted with a -15.75% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
For Q3 2025, Caris Life Sciences, Inc. Common Stock reported EPS of $0.08, beating estimates by 138.66%, and revenue of $216.83M, 26.17% above expectations.
The stock price moved down -15.75%, changed from $29.21 before the earnings release to $24.61 the day after.
The next earning report is scheduled for --.
Based on -- analysts, Caris Life Sciences, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung